Prevalence of Trimethoprim-Sulfamethoxazole Adverse Reaction Mislabelling in Australia
Prevalence of Trimethoprim-Sulfamethoxazole Adverse Reaction Mislabelling in Australia
About this item
Full title
Author / Creator
Publisher
Basel, Switzerland
Journal title
Language
English
Formats
Publication information
Publisher
Basel, Switzerland
Subjects
More information
Scope and Contents
Contents
Introduction: Trimethoprim-sulfamethoxazole (TMP-SMX) is an important antibiotic, with the most compelling indications for Pneumocystis jirovecii pneumonia prophylaxis and methicillin-resistant Staphylococcus aureus treatment. Previous adverse reactions (AR) to TMP-SMX may limit the usability of TMP-SMX. Electronic medical record (EMR) of AR for ot...
Alternative Titles
Full title
Prevalence of Trimethoprim-Sulfamethoxazole Adverse Reaction Mislabelling in Australia
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_karger_primary_531975
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_karger_primary_531975
Other Identifiers
ISSN
1018-2438
E-ISSN
1423-0097
DOI
10.1159/000531975
